Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$13.30 USD
-0.25 (-1.85%)
Updated May 31, 2024 04:00 PM ET
After-Market: $13.31 +0.01 (0.08%) 7:36 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.88 |
EPS Last Quarter | -0.97 |
Last EPS Surprise | -4.30% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.60 |
Next Year | -2.94 |
EPS (TTM) | -3.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.69M | 24.47M | 95.78M | 146.59M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 24.87M | 25.00M | 97.00M | 162.60M |
Low Estimate | 22.50M | 23.93M | 94.55M | 130.58M |
Year ago Sales | 21.14M | 20.85M | 82.71M | 95.78M |
Year over Year Growth Est. | 12.04% | 17.34% | 15.79% | 53.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.88 | -0.87 | -3.60 | -2.94 |
# of Estimates | 3 | 2 | 4 | 4 |
Most Recent Consensus | -0.83 | -0.86 | -3.48 | -3.18 |
High Estimate | -0.83 | -0.86 | -3.42 | -1.61 |
Low Estimate | -0.90 | -0.88 | -3.90 | -3.75 |
Year ago EPS | -1.03 | -0.68 | -3.55 | -3.60 |
Year over Year Growth Est. | 14.56% | -27.94% | -1.41% | 18.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 2 | 2 | 0 |
Up Last 60 Days | 1 | 2 | 2 | 0 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 3 |
Down Last 60 Days | 1 | 0 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.88 | -0.87 | -3.60 | -2.94 |
7 Days Ago | -0.86 | -0.90 | -3.60 | -2.95 |
30 Days Ago | -0.89 | -0.90 | -3.59 | -1.75 |
60 Days Ago | -0.89 | -0.90 | -3.59 | -1.75 |
90 Days Ago | -0.69 | -0.63 | -2.66 | -1.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.88 | -0.87 | -3.50 | -2.94 |
Zacks Consensus Estimate | -0.88 | -0.87 | -3.60 | -2.94 |
Earnings ESP | 0.00% | 0.00% | 2.78% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.97 | -0.72 | -0.68 | -1.03 | NA |
Estimate | -0.93 | -0.67 | -0.89 | -1.13 | NA |
Difference | -0.04 | -0.05 | 0.21 | 0.10 | 0.06 |
Surprise | -4.30% | -7.46% | 23.60% | 8.85% | 5.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more